Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection
- PMID: 21347781
- DOI: 10.1245/s10434-011-1609-3
Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection
Abstract
Background: Macrophages (Mφ) and regulatory T cells (Tregs) are the major components of the inflammatory infiltrate in virtually all tumors. The objective of this study was to investigate the prognostic significance of Mφ and Tregs infiltration in advanced gastric cancer after radical resection.
Methods: CD68(+) Mφ and FOXP3(+) Tregs were assessed by immunohistochemistry in tissues from 107 patients with surgically advanced gastric cancer. The microlocalization of Mφ and Tregs cells with respect to the development of gastric cancer were given special concern. Prognostic value of normal, peritumoral, and intratumoral Mφ and Tregs densities was evaluated by Kaplan-Meier analysis and Cox regression.
Results: The results showed that the presence of intratumoral CD68(+) Mφ was an independent prognostic factor for overall survival (OS) (P = 0.02). Moreover, the combination of high numbers of intratumoral CD68(+) Mφ and FOXP3(+) Tregs was associated with improved survival (P = 0.041). Five-year OS rate was only 27% for patients with low intratumoral Mφ and intratumoral Tregs compared with 62% for patients with high intratumoral Mφ and intratumoral Tregs. In addition, advanced intestinal-type gastric cancers were more likely to have fewer infiltrating Mφ than diffuse-type cancers (P = 0.024).
Conclusions: Association of intratumoral Mφ and Tregs is a promising independent predictor for survival in advanced gastric cancer. The results suggested that a combination of concomitant stimulation of intratumoral Mφ and Tregs may be an effective strategy for treatment of patients with advanced gastric cancer after radical resection.
Similar articles
-
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.J Clin Oncol. 2007 Jun 20;25(18):2586-93. doi: 10.1200/JCO.2006.09.4565. J Clin Oncol. 2007. PMID: 17577038
-
Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.Digestion. 2012;86(4):329-37. doi: 10.1159/000342801. Epub 2012 Nov 28. Digestion. 2012. PMID: 23207161
-
The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma.BJU Int. 2009 Feb;103(3):399-405. doi: 10.1111/j.1464-410X.2008.08151.x. Epub 2008 Nov 19. BJU Int. 2009. PMID: 19021626
-
Contribution of regulatory T cells to cancer: A review.J Cell Physiol. 2019 Jun;234(6):7983-7993. doi: 10.1002/jcp.27553. Epub 2018 Oct 14. J Cell Physiol. 2019. PMID: 30317612 Review.
-
Recent advances in the study of regulatory T cells in gastric cancer.Int Immunopharmacol. 2019 Aug;73:560-567. doi: 10.1016/j.intimp.2019.05.009. Epub 2019 Jun 7. Int Immunopharmacol. 2019. PMID: 31181438 Review.
Cited by
-
Translational Learnings in the Development of Chemo-Immunotherapy Combination to Bypass the Cold Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma.Front Oncol. 2022 May 18;12:835502. doi: 10.3389/fonc.2022.835502. eCollection 2022. Front Oncol. 2022. PMID: 35664786 Free PMC article. Review.
-
Macrophages in immunoregulation and therapeutics.Signal Transduct Target Ther. 2023 May 22;8(1):207. doi: 10.1038/s41392-023-01452-1. Signal Transduct Target Ther. 2023. PMID: 37211559 Free PMC article. Review.
-
Comprehensive analysis and experimental validation of disulfidptosis-associated prognostic signature and immune microenvironment characterization of gastric cancer.Cancer Immunol Immunother. 2025 Feb 25;74(4):116. doi: 10.1007/s00262-024-03883-3. Cancer Immunol Immunother. 2025. PMID: 39998563 Free PMC article.
-
Diagnostic and prognostic value of the peripheral natural killer cell levels in gastric cancer.Exp Ther Med. 2020 Oct;20(4):3816-3822. doi: 10.3892/etm.2020.9101. Epub 2020 Aug 5. Exp Ther Med. 2020. PMID: 32855731 Free PMC article.
-
Clinical significance of macrophage heterogeneity in human malignant tumors.Cancer Sci. 2014 Jan;105(1):1-8. doi: 10.1111/cas.12314. Epub 2013 Nov 29. Cancer Sci. 2014. PMID: 24168081 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical